Advanced non-small cell lung cancer. Surgery may not be the best option for a few reasons, including: The cancer has spread to many lymph nodes in the chest. ... If you had open surgery, the average ...

Early postoperative levels of IL-6 and CRP are independently associated with infection risk after pulmonary cancer surgery.

The new lung cancer screening program needs to be independently evaluated to keep it on track, and to minimise the harms.

CHEST guideline updates support minimally invasive resection and targeted therapy to enhance survival in Stage I–II NSCLC.

Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell ...

“This research shows that people with COPD seem to gather a lot more carbon in their lung cells. These cells also look and ...

Expanding eligibility criteria for lung cancer screening to include 20-year smoking history without requiring a certain ...

The aim is to find and treat lung cancers early, before they grow and spread, to improve the chance of survival. Here’s ...

Targeted therapies and immunotherapy can provide benefits when added to chemotherapy or may eliminate the need for ...